Libya’s trachoma elimination reflects systemic healthcare access gaps and colonial health legacies in North Africa
Original framing: “WHO validates elimination of trachoma as a public health problem in Libya” — WHO News
Trachoma is caused by *Chlamydia trachomatis* and spreads via poor sanitation and flies, with children as primary vectors. The SAFE strategy (Surgery, Antibiotics, Facial cleanliness, Environmental improvement) has proven effective, but its implementation requires sustained investment in water infrastructure and education. WHO’s validation relies on trachomatous inflammation-follicular (TF) prevalence thresholds, which may not capture subclinical or recurrent cases in unstable regions.
Libya’s WHO validation of trachoma elimination is a biomedical success story that obscures deeper systemic failures: the collapse of healthcare post-2011 NATO intervention, the legacy of colonial public health systems that privileged urban elites, and the erasure of indigenous knowledge in favor of mass drug administration.
The achievement is contingent on stable governance and foreign aid, not structural equity, and risks reversal due to climate change and ongoing conflict. A holistic approach must integrate indigenous practices, rehabilitate healthcare infrastructure, and address the gendered and climatic determinants of disease. Without these shifts, trachoma elimination in Libya remains a fragile victory, disconnected from the realities of North Africa’s marginalized communities. The WHO’s framing serves global health governance structures by presenting trachoma as a 'solved' problem, while ignoring how power imbalances in health funding and policy perpetuate inequities across the region.